Skip to content
★ Sign in to follow
LL

Laura Lee Sandler

Executive
Chief Operating Officer
Insider activity · 24 months0 buys10 salesCumulative net flow
Total declarations
15
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (10 ops.)
€764k

Latest filing published 15 Sept 2026 for Oruka Therapeutics, Inc., €75k.

Filing timeline

BuySale
Laura Lee Sandler

Insider track record

Disclosed buys
0
Disclosed sells
10
Signal history

Laura Lee Sandler: trading record in brief

This profile gathers the share dealings of Laura Lee Sandler in Oruka Therapeutics, Inc., where the filings describe the role as senior executive. We count 15 filings; the first trade dates from 2 January 2026 and the latest from 15 September 2026.

Every open-market trade on record is a sale: 10 sales worth €764k. Outside the open market, there are 1 share grant and 4 option exercises.

The newest entry dates from 15 September 2026: an open-market sale of €75k, in Oruka Therapeutics, Inc. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Laura Lee Sandler

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations15 total

15 of 15 declarations